Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | completed | Phase 1 | 62 | Bristol-Myers SquibbINDUSTRY | 3 | Jan 25, 2011 | clinicaltrials |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | terminated | Phase 1 | 10 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 6, 2011 | clinicaltrials |
| Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients |
| completed |
| Phase 1 / Phase 2 |
| 30 |
| Radboud University Medical CenterOTHER |
| 1 |
| Nov 30, 2010 |
| clinicaltrials |
| NCT00102024 | Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma | terminated | Phase 1 / Phase 2 | 30 | BiogenINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00084591 | Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | completed | Phase 1 | — | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | completed | Phase 1 / Phase 2 | 38 | PhotocureINDUSTRY | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00164658 | Evaluating Tools for Health Promotion and Disease Prevention | completed | Phase 1 | 8,400 | Centers for Disease Control and PreventionFED | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00496704 | Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan | unknown | Phase 1 / Phase 2 | 56 | Yonsei UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00854971 | Efficacy Study of TKcell in Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 86 | BinexINDUSTRY | 1 | May 18, 2009 | clinicaltrials |
| NCT00242788 | IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00422773 | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 21 | Technische Universität DresdenOTHER | 1 | Feb 27, 2009 | clinicaltrials |
| NCT00611000 | Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | completed | Phase 1 | 20 | Rockefeller UniversityOTHER | 0 | Feb 17, 2009 | clinicaltrials |
| NCT00331786 | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | completed | Phase 1 | 240 | Stony Brook UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00478946 | A Study of Picoplatin in Colorectal Cancer | unknown | Phase 1 / Phase 2 | 43 | Poniard PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00820417 | Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib | completed | Phase 1 | 63 | Harrison Clinical ResearchINDUSTRY | 2 | Jan 12, 2009 | clinicaltrials |
| NCT00524706 | Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 42 | Shizuoka Cancer CenterOTHER | 1 | Nov 13, 2008 | clinicaltrials |
| NCT00715325 | ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy | unknown | Phase 1 / Phase 2 | 200 | Stryker GI Ltd.INDUSTRY | 0 | Sep 18, 2008 | clinicaltrials |
| NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 63 | Stony Brook UniversityOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00443573 | Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer | suspended | Phase 1 / Phase 2 | 100 | ARCA Biopharma, Inc.INDUSTRY | 1 | May 7, 2008 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 2 | Jul 19, 2006 | clinicaltrials |
| NCT00250328 | Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy | unknown | Phase 1 | 40 | Hadassah Medical OrganizationOTHER | 1 | Nov 8, 2005 | clinicaltrials |
| NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 23 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00154713 | Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | unknown | Phase 1 / Phase 2 | 37 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00028405 | Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors | completed | Phase 1 | 48 | Light Sciences LLCINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00047762 | Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer | completed | Phase 1 | — | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jan 25, 2011source: clinicaltrials